Universitätsstraße 21/23
91054 Erlangen

Untergeordnete Organisationseinheiten

Lehrstuhl für Geburtshilfe und Frauenheilkunde

Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 12 Go to next page Go to last page

Krebs, J., Wasner, S., Egloffstein, S., Lux, M.P., Morawa, E., Beckmann, M., & Erim, Y. (2018). Resilience, Fear of Progression and Psychosocial Distress in Patients with Breast Cancer and Gynecological Tumors Seeking a Second Opinion. Psychotherapie Psychosomatik Medizinische Psychologie.
Würfel, F., Erber, R., Hübner, H., Hein, A., Lux, M.P., Jud, S.,... Rübner, M. (2018). TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes. Breast Care, 13(1), 8-14.
Heger, L., Balk, S., Lühr, J., Heidkamp, G., Lehmann, C., Hatscher, L.,... Dudziak, D. (2018). CLEC10A Is a Specific Marker for Human CD1c+ Dendritic Cells and Enhances Their Toll-Like Receptor 7/8-Induced Cytokine Secretion. Frontiers in Immunology, 9.
Schlichtig, K., Lechner, P., Grafe, C., Ferstl, B., Fuchs, F., Hein, A.,... Dorje, F. (2018). Medication safety in patients treated with new oral antitumor agents: A prospective, randomized investigation on the impact of intensified clinical pharmaceutical/clinical pharmacological care on patient safety, patient knowledge and patient well-being (AMBORA). Supported by the German Cancer Aid within the Comprehensive Cancer Center Erlangen-EMN. (pp. 198-198).
Wunderle, M., Gaß, P., Häberle, L., Flesch, V.M., Rauh, C., Bani, M.,... Hein, A. (2018). BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients. Breast Cancer Research and Treatment, 171(1), 85-94.
Siegler, L., Erber, R., Burghaus, S., Brodkorb, T., Wachter, D., Wilkinson, N.,... Agaimy, A. (2018). Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening. Virchows Archiv.
Earp, M., Tyrer, J.P., Winham, S.J., Lin, H.-Y., Chornokur, G., Dennis, J.,... Phelan, C.M. (2018). Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. PLoS ONE, 13(7).
Emons, J., Wunderle, M., Hartmann, A., Radicke, M., Rauh, C., Uder, M.,... Jud, S. (2018). Initial clinical results with a fusion prototype for mammography and three-dimensional ultrasound with a standard mammography system and a standard ultrasound probe. Acta Radiologica, 59(12), 1406-1413.
Grafe, C., Semrau, S., Hein, A., Beckmann, M., Mackensen, A., Dörje, F., & Fromm, M. (2018). Dose adjustment of cisplatin, etoposide, and ifosfamide according to kidney function: a retrospective analysis and implications for medication safety. Naunyn-Schmiedebergs Archives of Pharmacology, 391(2), 219-229.
Gaß, P., Untch, M., Mueller, V., Moebus, V., Thomssen, C., Häberle, L.,... Nabieva, N. (2018). Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians. Geburtshilfe und Frauenheilkunde, 78(7), 707-714.
Huebner, H., Knoerr, B., Betzler, A., Hartner, A., Kehl, S., Baier, F.,... Rübner, M. (2018). Detyrosinated tubulin is decreased in fetal vessels of preeclampsia placentas. Placenta, 62, 58-65.
Painter, J.N., O'Mara, T.A., Morris, A.P., Cheng, T.H.T., Gorman, M., Martin, L.,... Spurdle, A.B. (2018). Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. Cancer Medicine, 7(5), 1978-1987.
Brennan, M., Gaß, P., Häberle, L., Wang, D., Hartmann, A., Lux, M.P.,... Fasching, P.A. (2018). The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer. Breast Cancer Research and Treatment, 171(3), 747-758.
Wunderle, M., Olmes, G., Nabieva, N., Häberle, L., Jud, S., Hein, A.,... Fasching, P.A. (2018). Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data. Geburtshilfe und Frauenheilkunde, 78(5), 481-492.
Poehls, U.G., Hack, C., Ekici, A.B., Beckmann, M., Fasching, P.A., Rübner, M., & Hübner, H. (2018). Saliva samples as a source of DNA for high throughput genotyping: an acceptable and sufficient means in improvement of risk estimation throughout mammographic diagnostics. European Journal of Medical Research, 23(1).
Gebrekidan, M., Erber, R., Hartmann, A., Fasching, P.A., Emons, J., Beckmann, M., & Bräuer, A. (2018). Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS). Technology in Cancer Research & Treatment, 17.
Hoyer, J., Vasileiou, G., Uebe, S., Wunderle, M., Kraus, C., Fasching, P.A.,... Reis, A. (2018). Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria. Bmc Cancer, 18(1).
O'Mara, T.A., Glubb, D.M., Amant, F., Annibali, D., Ashton, K., Attia, J.,... Thompson, D.J. (2018). Identification of nine new susceptibility loci for endometrial cancer. Nature Communications, 9(1).
Hack, C., Stoll, M., Jud, S., Heusinger, K., Adler, W., Haeberle, L.,... Bayer, C.M. (2017). Correlation of mammographic density and serum calcium levels in patients with primary breast cancer. Cancer Medicine, 6(6), 1473-1481.
Milne, R.L., Kuchenbaecker, K.B., Michailidou, K., Beesley, J., Kar, S., Lindstrom, S.,... Simard, J. (2017). Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nature Genetics, 49(12), 1767-1778.

Zuletzt aktualisiert 2016-05-05 um 04:59